Related Experiment Videos
Thrombocytosis in intensive care.
1Directorate of Anaesthesia and Intensive Care, North Staffordshire Hospital, Stoke-on-Trent, UK.
British Journal of Anaesthesia
|March 7, 2002
Summary
Thrombocytosis, or high platelet count, is common in intensive care unit (ICU) patients. This condition was linked to reduced mortality but longer ICU stays, suggesting it may predict a better outcome.
Area of Science:
- Critical Care Medicine
- Hematology
- Clinical Pathology
Background:
- Thrombocytosis is defined as an elevated platelet count.
- The incidence and clinical significance of thrombocytosis in intensive care unit (ICU) patients require further elucidation.
Purpose of the Study:
- To investigate the incidence of thrombocytosis in critically ill patients.
- To explore the association between thrombocytosis and patient outcomes, including ICU stay duration and mortality.
Main Methods:
- A retrospective study was conducted on 226 patients admitted to the ICU.
- Platelet counts were analyzed to identify cases of thrombocytosis (platelet count > 450x10(9)/L).
- Data on admission category, ICU stay duration, and mortality were collected and analyzed.
Main Results:
- Thrombocytosis was observed in 21.7% of the studied ICU patients.
- Patients with thrombocytosis had significantly lower ICU mortality (P=0.003) and hospital mortality (P=0.006).
- A longer duration of ICU stay was associated with thrombocytosis (P<0.0001).
Conclusions:
- Thrombocytosis is a frequent finding in the ICU population.
- Elevated platelet counts in ICU patients may be an independent predictor of a favorable outcome.
- Further research is warranted to understand the mechanisms underlying this association.